BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16251361)

  • 1. Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.
    Määttä JA; Sundvall M; Junttila TT; Peri L; Laine VJ; Isola J; Egeblad M; Elenius K
    Mol Biol Cell; 2006 Jan; 17(1):67-79. PubMed ID: 16251361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis.
    Zeng F; Zhang MZ; Singh AB; Zent R; Harris RC
    Mol Biol Cell; 2007 Nov; 18(11):4446-56. PubMed ID: 17761534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis.
    Wali VB; Gilmore-Hebert M; Mamillapalli R; Haskins JW; Kurppa KJ; Elenius K; Booth CJ; Stern DF
    Breast Cancer Res; 2014 Dec; 16(6):501. PubMed ID: 25516216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell death or survival promoted by alternative isoforms of ErbB4.
    Sundvall M; Veikkolainen V; Kurppa K; Salah Z; Tvorogov D; van Zoelen EJ; Aqeilan R; Elenius K
    Mol Biol Cell; 2010 Dec; 21(23):4275-86. PubMed ID: 20943952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective cleavage of ErbB4 by G-protein-coupled gonadotropin-releasing hormone receptor in cultured hypothalamic neurons.
    Higa-Nakamine S; Maeda N; Toku S; Yamamoto T; Yingyuenyong M; Kawahara M; Yamamoto H
    J Cell Physiol; 2012 Jun; 227(6):2492-501. PubMed ID: 21898395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
    Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase.
    Elenius K; Choi CJ; Paul S; Santiestevan E; Nishi E; Klagsbrun M
    Oncogene; 1999 Apr; 18(16):2607-15. PubMed ID: 10353604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ErbB1 and ErbB4 generate opposing signals regulating mesenchymal cell proliferation during valvulogenesis.
    Iwamoto R; Mine N; Mizushima H; Mekada E
    J Cell Sci; 2017 Apr; 130(7):1321-1332. PubMed ID: 28232522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cleavable ErbB4 isoform in estrogen receptor-regulated growth of breast cancer cells.
    Junttila TT; Sundvall M; Lundin M; Lundin J; Tanner M; Härkönen P; Joensuu H; Isola J; Elenius K
    Cancer Res; 2005 Feb; 65(4):1384-93. PubMed ID: 15735025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presenilin-dependent gamma-secretase processing regulates multiple ERBB4/HER4 activities.
    Vidal GA; Naresh A; Marrero L; Jones FE
    J Biol Chem; 2005 May; 280(20):19777-83. PubMed ID: 15746097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of the four isoforms of receptor tyrosine kinase ErbB4, but not ErbB1, confers cardiomyocyte hypertrophy.
    Wang Z; Chan HW; Gambarotta G; Smith NJ; Purdue BW; Pennisi DJ; Porrello ER; O'Brien SL; Reichelt ME; Thomas WG; Paravicini TM
    J Cell Physiol; 2021 Dec; 236(12):8160-8170. PubMed ID: 34170016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells.
    Muraoka-Cook RS; Sandahl M; Husted C; Hunter D; Miraglia L; Feng SM; Elenius K; Earp HS
    Mol Biol Cell; 2006 Sep; 17(9):4118-29. PubMed ID: 16837552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms.
    Hollmén M; Määttä JA; Bald L; Sliwkowski MX; Elenius K
    Oncogene; 2009 Mar; 28(10):1309-19. PubMed ID: 19151766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ErbB/HER family of protein-tyrosine kinases and cancer.
    Roskoski R
    Pharmacol Res; 2014 Jan; 79():34-74. PubMed ID: 24269963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Removal of cell surface heparan sulfate increases TACE activity and cleavage of ErbB4 receptor.
    Määttä JA; Olli K; Henttinen T; Tuittila MT; Elenius K; Salmivirta M
    BMC Cell Biol; 2009 Jan; 10():5. PubMed ID: 19171023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ErbB4 expression in neural progenitor cells (ST14A) is necessary to mediate neuregulin-1beta1-induced migration.
    Gambarotta G; Garzotto D; Destro E; Mautino B; Giampietro C; Cutrupi S; Dati C; Cattaneo E; Fasolo A; Perroteau I
    J Biol Chem; 2004 Nov; 279(47):48808-16. PubMed ID: 15355992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4.
    Rio C; Buxbaum JD; Peschon JJ; Corfas G
    J Biol Chem; 2000 Apr; 275(14):10379-87. PubMed ID: 10744726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYT-1 isoform of ErbB4 is an independent prognostic factor in serous ovarian cancer and selectively promotes ovarian cancer cell growth in vitro.
    Paatero I; Lassus H; Junttila TT; Kaskinen M; Bützow R; Elenius K
    Gynecol Oncol; 2013 Apr; 129(1):179-87. PubMed ID: 23313737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential nuclear localization and kinase activity of alternative ErbB4 intracellular domains.
    Sundvall M; Peri L; Määttä JA; Tvorogov D; Paatero I; Savisalo M; Silvennoinen O; Yarden Y; Elenius K
    Oncogene; 2007 Oct; 26(48):6905-14. PubMed ID: 17486069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-α converting enzyme-mediated ErbB4 transactivation by TNF promotes colonic epithelial cell survival.
    Hilliard VC; Frey MR; Dempsey PJ; Peek RM; Polk DB
    Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G338-46. PubMed ID: 21617117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.